|2.87||-0.14 / -4.65%|
Data as of 3:59pm ET
|2.89||+0.0183 / +0.64%|
The 2 analysts offering 12-month price forecasts for Oncothyreon Inc have a median target of 5.00, with a high estimate of 6.00 and a low estimate of 4.00. The median estimate represents a +74.22% increase from the last price of 2.87.
The current consensus among 3 polled investment analysts is to Buy stock in Oncothyreon Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.